Inventor · disambiguated record
Holger Siebeneicher
Also filed as: SIEBENEICHER HOLGER
14 granted patents·12 pending applications·80 citations·filing 2009–2022
90Inventor score
Top patents by PatentIndex Score
26 records- 0195US10308634B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2015·Granted Jun 4, 2019·17 cites·27 claims
- 0292US10793545B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2019·Granted Oct 6, 2020·7 cites·27 claims
- 0391US9345793B2Compounds for binding to the platelet specific glycoprotein IIB/IIIA and their use for imaging of thrombiBERGER MARKUS·Filed 2012·Granted May 24, 2016·10 cites·15 claims
- 0490US12006303B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·24 claims
- 0590US12006304B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·9 claims
- 0690US9951086B2Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicamentsBayer Pharma AG·Filed 2014·Granted Apr 24, 2018·21 cites·19 claims
- 0788US9957235B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted May 1, 2018·8 cites·34 claims
- 0886US9951027B2Benzimidazol-2-amines as MIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted Apr 24, 2018·8 cites·22 claims
- 0985US10435396B22-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugsBayer Pharma AG·Filed 2017·Granted Oct 8, 2019·7 cites·8 claims
- 1070US2021053941A1Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2020·Application pending·0 cites
- 1169US2022241261A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2021·Application pending·0 cites
- 1267US2019388410A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2019·Application pending·0 cites
- 1357US2018289685A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2016·Application pending·0 cites
- 1453US2024239804A1Furoindazole derivatives as antagonists or inhibitors of gpr84BAYER AG·Filed 2022·Application pending·0 cites
- 1551US10442772B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2018·Granted Oct 15, 2019·0 cites·21 claims
- 1651US2024417407A1Furoindazole derivatives as gpr84 antagonistsBAYER AG·Filed 2022·Application pending·0 cites
- 1749US9744252B2Compounds for binding to the platelet specific glycoprotein IIb/IIIa and their use for imaging of thrombiPIRAMAL IMAGING SA·Filed 2016·Granted Aug 29, 2017·0 cites·15 claims
- 1849US2011250137A1Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparationBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 1944US2017037028A1Glucose transport inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2042US2020085791A1[(phenylsulfonyl)octahydro-epiminoisoindol-yl](1h-1,2,3-triazol-5-yl)methanonesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2140US11319324B2Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitorsBAYER AG·Filed 2018·Granted May 3, 2022·0 cites·11 claims
- 2237US10167293B2[8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanonesBayer Pharma AG·Filed 2017·Granted Jan 1, 2019·0 cites·18 claims
- 2337US2020079758A1[4-(phenylsulfonyl)piperazin-1-yl](1h-1,2,3-triazol-4-yl)methanonesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2435US8968701B2Usage of low to medium-pressure liquid chromatography for the purification of radiotracersSIEBENEICHER HOLGER·Filed 2010·Granted Mar 3, 2015·0 cites·9 claims
- 2535US2020087284A1[4-(phenylsulfonyl)piperazin-1-yl](1h-1, 2, 3-triazol-4-yl)methanonesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2634US2013034497A1Iodine-labeled homoglutamic acid and glutamic acid derivativesPIRAMAL IMAGING SA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Holger Siebeneicher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →